Feed PTIXW
PT

Protagenic Therapeutics, Inc. PTIXW · NASDAQ

$0.02 +0.00% (+$0.00)

Summary

73 / 100 · Bulios Score

What speaks for it

  • Out of every 100 USD of revenue, 35,481 USD is left as net profit.
  • It earns 149 USD a year on every 100 USD of invested capital.
  • It has no debt and holds $362.5K in cash.
  • The share price is below the Bulios Fair Price.

What to watch

  • It passes only 2 of the 9 points of the Piotroski financial health test.
  • For every 100 USD of bills due within a year it has 29 USD of short-term assets.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Current price $0.016

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Valuation in detail

Is it growing?

Revenue (USD)

There is not enough revenue history yet to say how fast it grows.

Growth in detail

Does it make money?

Income figures for the last 12 months are not available.

Profitability in detail

Is it financially healthy?

Yes

It has no debt.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

What does it earn on?

By product

This revenue breakdown is on the way.

By region

This revenue breakdown is on the way.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.